arrow
O

Onyema Ogbuagu

Yale University
H指数:22
被引数:3,225

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 study

lenacapavir、teropavimab和zinlirvimab的疗效与安全性:一项多中心、开放标签、随机、活性对照、二期研究的第26周主要结局结果

2026-02-170
OAAI
Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study

皮下注射Lenacapavir在多重耐药HIV-1感染者中的应用:CAPELLA研究的156周结果

2026-01-010
PRE
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study

奥贝德西韦在低风险、非住院COVID-19患者中的有效性与安全性(OAKTREE):一项III期、随机、双盲、安慰剂对照研究

2025-07-140
PRE
Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study

奥贝拉米韦用于无进展至重症疾病风险因素成人和青少年COVID-19患者的治疗:OAKTREE研究

2025-01-290
PRE
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
2024-11-272
PRE
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial
2024-08-2910
PRE
A continent-wide effort and solidarity at curbing COVID-19 pandemic: the Africa task force for novel coronavirus (AFTCOR) infection prevention and control technical working group's experience
2023-05-154
OAAI